Analysts Set Teladoc Health, Inc. (NYSE:TDOC) Target Price at $11.26

Shares of Teladoc Health, Inc. (NYSE:TDOC) have been assigned an average rating of “Hold” from the eighteen research firms that are currently covering the stock, Marketbeat Ratings reports. Eleven analysts have rated the stock with a hold rating and seven have issued a buy rating on the company. The average 1 year target price among analysts that have updated their coverage on the stock in the last year is $11.26.

TDOC has been the subject of several analyst reports. Oppenheimer cut their price target on shares of Teladoc Health from $14.00 to $12.00 and set an “outperform” rating for the company in a report on Friday, January 24th. The Goldman Sachs Group lowered their price target on shares of Teladoc Health from $16.00 to $13.00 and set a “buy” rating for the company in a research note on Monday, March 3rd. Piper Sandler decreased their price objective on shares of Teladoc Health from $13.00 to $12.00 and set an “overweight” rating on the stock in a research report on Thursday, February 27th. Royal Bank of Canada boosted their price target on shares of Teladoc Health from $11.00 to $12.00 and gave the company an “outperform” rating in a research report on Friday, January 24th. Finally, Needham & Company LLC reissued a “hold” rating on shares of Teladoc Health in a research note on Thursday, February 27th.

Institutional Trading of Teladoc Health

Several institutional investors have recently made changes to their positions in the business. Vanguard Group Inc. grew its position in shares of Teladoc Health by 5.9% during the fourth quarter. Vanguard Group Inc. now owns 18,463,155 shares of the health services provider’s stock worth $167,830,000 after purchasing an additional 1,029,829 shares in the last quarter. Point72 Asset Management L.P. grew its position in shares of Teladoc Health by 33.6% during the fourth quarter. Point72 Asset Management L.P. now owns 11,179,863 shares of the health services provider’s stock worth $101,625,000 after purchasing an additional 2,813,568 shares in the last quarter. Renaissance Technologies LLC grew its position in shares of Teladoc Health by 15.5% during the fourth quarter. Renaissance Technologies LLC now owns 5,674,542 shares of the health services provider’s stock worth $51,582,000 after purchasing an additional 763,265 shares in the last quarter. Geode Capital Management LLC boosted its stake in Teladoc Health by 0.6% during the fourth quarter. Geode Capital Management LLC now owns 3,947,831 shares of the health services provider’s stock valued at $35,894,000 after buying an additional 22,664 shares during the last quarter. Finally, Maple Rock Capital Partners Inc. boosted its stake in Teladoc Health by 189.5% during the fourth quarter. Maple Rock Capital Partners Inc. now owns 3,561,000 shares of the health services provider’s stock valued at $32,369,000 after buying an additional 2,331,000 shares during the last quarter. Hedge funds and other institutional investors own 76.82% of the company’s stock.

Teladoc Health Price Performance

TDOC stock opened at $8.17 on Tuesday. The stock has a market capitalization of $1.42 billion, a PE ratio of -1.42 and a beta of 1.27. The company’s 50-day moving average is $10.45 and its 200-day moving average is $9.72. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69. Teladoc Health has a 1 year low of $6.76 and a 1 year high of $15.68.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings results on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.21) by ($0.07). Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. The company had revenue of $640.49 million for the quarter, compared to analysts’ expectations of $639.44 million. Equities research analysts expect that Teladoc Health will post -1.16 EPS for the current fiscal year.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.